ONCY
Oncolytics Biotech Inc.
There isn't enough reported data to score ONCY yet.
ONCY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ONCY's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
ONCY PE Valuation
ONCY has no meaningful PE right now: it lost money over the past year.
ONCY Forward outlook
There aren't enough analyst estimates for ONCY to show an outlook.
ONCY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$0.25 | +$0.09 |
| Q2 2024 | -$0.27 | +$0.03 |
| Q1 2024 | -$0.28 | +$0.01 |
| Q4 2023 | -$0.28 | +$0.02 |
| Q3 2023 | -$0.34 | -$0.04 |
| Q2 2023 | -$0.30 | +$0.01 |
| Q1 2023 | -$0.29 | +$0.05 |
| Q4 2022 | -$0.30 | +$0.05 |
ONCY is still losing money, but far less than before: $0.25 per share over the past year, against $0.86 at its worst in late 2019.
ONCY Quarterly Revenue
ONCY's revenue is shrinking: $0 last quarter.
ONCY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$8.1M | -$5.3M |
| Q1 2026 | -$7.3M | -$4M |
| Q4 2025 | -$4.7M | +$522.2K |
| Q3 2025 | -$4.8M | -$1.4M |
| Q2 2025 | -$2.8M | +$2.1M |
| Q1 2025 | -$3.3M | +$2M |
| Q4 2024 | -$5.3M | -$949.1K |
| Q3 2024 | -$3.4M | +$819.7K |
ONCY has burned cash in almost every quarter: −$25M over the past year, against −$15M the year before.
ONCY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.6% | +7.4M shares |
| 1 year | +41% | +35.1M shares |
| 3 years | +101% | +60.2M shares |
| 5 years | +187% | +78M shares |
| Available history | +429% | +97.1M shares |
ONCY has 120M diluted shares, up 41% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
ONCY Net Leverage
ONCY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ONCY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.7 | Oversold |
| Stochastic | 5.3 | Oversold |
ONCY's weekly RSI is 28 (oversold) and its Stochastic is 5 (oversold).
ONCY PE vs Healthcare Sector
ONCY has no meaningful PE right now: it lost money over the past year.
ONCY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.51 | 27% below |
| 20 week MA | $0.70 | 47% below |
| 50 week MA | $0.86 | 57% below |
| 100 week MA | $0.86 | 57% below |
| 200 week MA | $1.15 | 68% below |
ONCY is in a downtrend: it's below all five of its weekly moving averages, and 68% below its 200-week average.
ONCY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.84 | $2.56 | -9.9% |
| 2021 | $2.56 | $1.49 | -42% |
| 2022 | $1.49 | $1.69 | +13% |
| 2023 | $1.69 | $1.35 | -20% |
| 2024 | $1.35 | $0.99 | -27% |
| 2025 | $0.99 | $0.95 | -4% |
| 2026 YTD | $0.95 | $0.37 | -61% |
ONCY has finished three years in a row lower, and it's down 61% so far in 2026.